YLT-11, a Novel PLK4 Inhibitor, Inhibits Human Breast Cancer Growth via Inducing Maladjusted Centriole Duplication and Mitotic Defect

Cell Death and Disease - United Kingdom
doi 10.1038/s41419-018-1071-2